Bovine Blood Plasma Derivatives Market Product, Derivatives Type, Source - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
소 혈장 유도체 시장 - 조사 범위
TMR의 조사 리포트 '세계의 소 혈장 유도체 시장'은 2024-2034년의 예측 기간에 시장의 지표에 관한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사하고 있습니다. 2024년을 기준년, 2034년을 예측년으로 2018-2034년의 세계 소 혈장 유도체 시장의 매출과 예측을 제공하고 있습니다. 또한 2024-2034년의 세계 소 혈장 유도체 시장의 연평균 성장률(CAGR %)도 게재하고 있습니다.
본 리포트는 광범위한 조사를 거쳐 작성되고 있습니다. 1차 조사에서는 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 메이커에 대한 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 애뉴얼 리포트, 프레스 릴리스, 관련 자료 등을 참조하여 소 혈장 유도체 시장을 추측했습니다.
| 시장 스냅숏 |
| 2023년 시장 규모 |
20억 달러 |
| 2034년 시장 규모 |
37억 달러 |
| CAGR |
5.8% |
세계의 소 혈장 유도체 시장의 경쟁 구도에 대해 조사하고 있습니다. 세계의 소 혈장 유도체 시장에서 사업을 운영하는 주요 기업이 식별되고, 각 기업이 다양한 속성으로 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 동향, SWOT 등이 본 리포트에서 소개하고 있는 세계의 소 혈장 유도체 시장에서 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 개요 : 세계 시장
제4장 시장 개요
- 서론
- 개요
- 시장 역학
- 세계의 시장 분석과 예측, 2020-2034년
- Porter's Five Forces 분석
제5장 주요 인사이트
- 밸류체인 분석
- 밸류체인에서 주요 기업
- 주요 최종사용자 리스트
- Porter's Five Forces 분석
- 2010-2030년까지 원료 소 혈장의 가격 동향
- 세계 : 수요와 공급 시나리오
- 규제 시나리오
- 주요 업계 이벤트
- 기술 개요
- 개요 프로세스
- 소 혈청 알부민(BSA)
- 면역글로불린
- 소 태아 혈청(FBS)
- 기술 - 혈액 채취와 처리 방법의 개요
- 소 혈장 수량의 개요
- 유통업체의 상황
- 주요 브랜드 분석
- 산업에 대한 COVID-19 팬데믹의 영향(밸류체인과 단기·중기·장기적 영향)
제6장 세계 시장 분석과 예측 : 제품별
- 서론과 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 제품별, 2020-2034년
- 시장의 매력 분석 : 제품별
제7장 세계 시장 분석과 예측 : 기술별
- 서론과 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 기술별, 2020-2034년
- 시장의 매력 분석 : 기술별
제8장 세계 시장 분석과 예측 : 파생형별
- 서론과 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 파생형별, 2020-2034년
- 면역글로불린
- 피브리노겐
- 혈청알부민
- 소 태아 혈청
- 트롬빈
- 트랜스페린
- 기타
- 시장의 매력 분석 : 파생형별
제9장 세계 시장 분석과 예측 : 소스별
- 서론과 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 소스별, 2020-2034년
- 시장의 매력 분석 : 소스별
제10장 세계 시장 분석과 예측 : 최종사용자별
- 서론과 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 최종사용자별, 2020-2034년
- 수의 업계
- 동물병원
- 수의학 참고 연구소
- POC/사내 테스트
- 수의 조사실
- 식품 산업
- 학술연구기관
- 세포배양/바이오테크놀러지
- 화장품 업계
- 제약 업계
- 진단 업계
- 기타
- 시장의 매력 분석 : 최종사용자별
제11장 세계 시장 분석과 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별, 2020-2034년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 시장의 매력 분석 : 지역별
제12장 북미의 시장 분석과 예측
제13장 유럽의 시장 분석과 예측
제14장 아시아태평양의 시장 분석과 예측
제15장 라틴아메리카의 시장 분석과 예측
제16장 중동 및 아프리카의 시장 분석과 예측
제17장 경쟁 구도
- 시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
- 시장 점유율 분석 : 기업별(2023년)
- 기업 개요
- ANZCO Foods(Itoham Yonekyu Holdings)
- Bovogen Biologicals Pty Ltd.(ANZCO Foods Healthcare)
- Moregate Biotech(ANZCO Foods)
- Proliant Health & Biologicals
- LAMPIRE Biological Laboratories, Inc.
- Rocky Mountain Biologicals, LLC
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich(Merck KGaA)
- Kraeber & Co GmbH
- Auckland BioSciences
- Lake Immunogenics
KSA
Bovine Blood Plasma Derivatives Market - Scope of Report
TMR's report on the global bovine blood plasma derivatives market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bovine blood plasma derivatives market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bovine blood plasma derivatives market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bovine blood plasma derivatives market.
| Market Snapshot |
|---|
| Market Value in 2023 | US$ 2 Bn |
| Market Value in 2034 | US$ 3.7 Bn |
| CAGR | 5.8% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bovine blood plasma derivatives market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bovine blood plasma derivatives market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bovine blood plasma derivatives market.
The report delves into the competitive landscape of the global bovine blood plasma derivatives market. Key players operating in the global bovine blood plasma derivatives market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bovine blood plasma derivatives market profiled in this report.
Key Questions Answered in Global bovine blood plasma derivatives Market Report:
- What is the sales/revenue generated by bovine blood plasma derivatives across all regions during the forecast period?
- What are the opportunities in the global bovine blood plasma derivatives market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Bovine Blood Plasma Derivatives Market - Research Objectives and Research Approach
The comprehensive report on the global bovine blood plasma derivatives market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global bovine blood plasma derivatives market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bovine blood plasma derivatives market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bovine Blood Plasma Derivatives Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Bn)
- 4.4.2. Market Volume/Unit Shipments Projections
- 4.5. Porter's Five Forces Analysis
5. Key Insights
- 5.1. Value Chain Analysis
- 5.1.1. Prominent Companies in Bovine Blood Plasma Derivatives Value Chain
- 5.1.2. List of Key End-user
- 5.2. Porters Five Forces of Analysis
- 5.3. Price trend of raw material bovine plasma from 2010-2030
- 5.4. Global Bovine Blood Plasma Derivatives: Demand and Supply Scenario
- 5.5. Regulatory Scenarios
- 5.6. Key Industry Events
- 5.7. Technology Overview
- 5.7.1. Overview of Bovine Blood Plasma Derivatives Process
- 5.7.1.1. Bovine Serum Albumin (BSA)
- 5.7.1.2. Immunoglobulin
- 5.7.1.3. Fetal Bovine Serum (FBS)
- 5.7.1.4. Technology -Summary of blood collection and processing methods
- 5.7.2. Overview of Bovine Blood Plasma Yield
- 5.8. Distributors Landscape
- 5.9. Major Brand Analysis
- 5.10. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2020-2034
- 6.3.1. Kits and Reagents
- 6.3.2. Instruments
- 6.3.3. Software and Service
- 6.4. Market Attractiveness Analysis, by Product
7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Technology
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Technology, 2020-2034
- 7.3.1. Molecular Diagnostics
- 7.3.2. Hematology
- 7.3.3. Immunodiagnostics
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by Technology
8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by Derivative Type, 2020-2034
- 8.3.1. Immunoglobulin
- 8.3.2. Fibrinogen
- 8.3.3. Serum Albumin
- 8.3.4. Fetal Bovine Serum
- 8.3.5. Thrombin
- 8.3.6. Transferrin
- 8.3.7. Others
- 8.4. Market Attractiveness Analysis, by Derivative Type
9. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Source
- 9.1. Introduction & Definition
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by Source, 2020-2034
- 9.3.1. US Grade
- 9.3.2. Australia Grade
- 9.3.3. New Zealand Grade
- 9.3.4. Others
- 9.4. Market Attractiveness Analysis, by Source
10. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by End-user
- 10.1. Introduction & Definition
- 10.2. Key Findings/Developments
- 10.3. Market Value Forecast, by End-user, 2020-2034
- 10.3.1. Veterinary Industry
- 10.3.1.1. Veterinary Hospitals
- 10.3.1.2. Veterinary Reference Laboratories
- 10.3.1.3. POC/In House Testing
- 10.3.1.4. Veterinary Research laboratories
- 10.3.2. Food Industry
- 10.3.3. Academic and Research Institutes
- 10.3.4. Cell Culture/ Biotechnology
- 10.3.5. Cosmetic Industry
- 10.3.6. Pharmaceutical Industry
- 10.3.7. Diagnostics Industry
- 10.3.8. Others
- 10.4. Market Attractiveness Analysis, by End-user
11. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Region, 2020-2034
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
- 11.3. Market Attractiveness Analysis, by Region
12. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2020-2034
- 12.2.1. Kits and Reagents
- 12.2.2. Instruments
- 12.2.3. Software and Service
- 12.3. Market Value Forecast, by Technology, 2020-2034
- 12.3.1. Molecular Diagnostics
- 12.3.2. Hematology
- 12.3.3. Immunodiagnostics
- 12.3.4. Others
- 12.4. Market Value Forecast, by Derivative Type, 2020-2034
- 12.4.1. Immunoglobulin
- 12.4.2. Fibrinogen
- 12.4.3. Serum Albumin
- 12.4.4. Fetal Bovine Serum
- 12.4.5. Thrombin
- 12.4.6. Transferrin
- 12.4.7. Others
- 12.5. Market Value Forecast, by Source, 2020-2034
- 12.5.1. US Grade
- 12.5.2. Australia Grade
- 12.5.3. New Zealand Grade
- 12.5.4. Others
- 12.6. Market Value Forecast, by End-user, 2020-2034
- 12.6.1. Veterinary Industry
- 12.6.1.1. Veterinary Hospitals
- 12.6.1.2. Veterinary Reference Laboratories
- 12.6.1.3. POC/In House Testing
- 12.6.1.4. Veterinary Research laboratories
- 12.6.2. Food Industry
- 12.6.3. Academic and Research Institutes
- 12.6.4. Cell Culture/ Biotechnology
- 12.6.5. Cosmetic Industry
- 12.6.6. Pharmaceutical Industry
- 12.6.7. Diagnostics Industry
- 12.6.8. Others
- 12.7. Market Value Forecast, by Country, 2020-2034
- 12.7.1. U.S.
- 12.7.2. Canada
- 12.8. Market Attractiveness Analysis
- 12.8.1. By Product
- 12.8.2. By Technology
- 12.8.3. By Derivative Type
- 12.8.4. By Source
- 12.8.5. By End-user
- 12.8.6. By Country
13. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2020-2034
- 13.2.1. Kits and Reagents
- 13.2.2. Instruments
- 13.2.3. Software and Service
- 13.3. Market Value Forecast, by Technology, 2020-2034
- 13.3.1. Molecular Diagnostics
- 13.3.2. Hematology
- 13.3.3. Immunodiagnostics
- 13.3.4. Others
- 13.4. Market Value Forecast, by Derivative Type, 2020-2034
- 13.4.1. Immunoglobulin
- 13.4.2. Fibrinogen
- 13.4.3. Serum Albumin
- 13.4.4. Fetal Bovine Serum
- 13.4.5. Thrombin
- 13.4.6. Transferrin
- 13.4.7. Others
- 13.5. Market Value Forecast, by Source, 2020-2034
- 13.5.1. US Grade
- 13.5.2. Australia Grade
- 13.5.3. New Zealand Grade
- 13.5.4. Others
- 13.6. Market Value Forecast, by End-user, 2020-2034
- 13.6.1. Veterinary Industry
- 13.6.1.1. Veterinary Hospitals
- 13.6.1.2. Veterinary Reference Laboratories
- 13.6.1.3. POC/In House Testing
- 13.6.1.4. Veterinary Research laboratories
- 13.6.2. Food Industry
- 13.6.3. Academic and Research Institutes
- 13.6.4. Cell Culture/ Biotechnology
- 13.6.5. Cosmetic Industry
- 13.6.6. Pharmaceutical Industry
- 13.6.7. Diagnostics Industry
- 13.6.8. Others
- 13.7. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.7.1. Germany
- 13.7.2. UK
- 13.7.3. France
- 13.7.4. Italy
- 13.7.5. Spain
- 13.7.6. Rest of Europe
- 13.8. Market Attractiveness Analysis
- 13.8.1. By Product
- 13.8.2. By Technology
- 13.8.3. By Derivative Type
- 13.8.4. By Source
- 13.8.5. By End-user
- 13.8.6. By Country/Sub-region
14. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2020-2034
- 14.2.1. Kits and Reagents
- 14.2.2. Instruments
- 14.2.3. Software and Service
- 14.3. Market Value Forecast, by Technology, 2020-2034
- 14.3.1. Molecular Diagnostics
- 14.3.2. Hematology
- 14.3.3. Immunodiagnostics
- 14.3.4. Others
- 14.4. Market Value Forecast, by Derivative Type, 2020-2034
- 14.4.1. Immunoglobulin
- 14.4.2. Fibrinogen
- 14.4.3. Serum Albumin
- 14.4.4. Fetal Bovine Serum
- 14.4.5. Thrombin
- 14.4.6. Transferrin
- 14.4.7. Others
- 14.5. Market Value Forecast, by Source, 2020-2034
- 14.5.1. US Grade
- 14.5.2. Australia Grade
- 14.5.3. New Zealand Grade
- 14.5.4. Others
- 14.6. Market Value Forecast, by End-user, 2020-2034
- 14.6.1. Veterinary Industry
- 14.6.1.1. Veterinary Hospitals
- 14.6.1.2. Veterinary Reference Laboratories
- 14.6.1.3. POC/In House Testing
- 14.6.1.4. Veterinary Research laboratories
- 14.6.2. Food Industry
- 14.6.3. Academic and Research Institutes
- 14.6.4. Cell Culture/ Biotechnology
- 14.6.5. Cosmetic Industry
- 14.6.6. Pharmaceutical Industry
- 14.6.7. Diagnostics Industry
- 14.6.8. Others
- 14.7. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.7.1. China
- 14.7.2. Japan
- 14.7.3. India
- 14.7.4. Australia & New Zealand
- 14.7.5. Rest of Asia Pacific
- 14.8. Market Attractiveness Analysis
- 14.8.1. By Product
- 14.8.2. By Technology
- 14.8.3. By Derivative Type
- 14.8.4. By Source
- 14.8.5. By End-user
- 14.8.6. By Country/Sub-region
15. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2020-2034
- 15.2.1. Kits and Reagents
- 15.2.2. Instruments
- 15.2.3. Software and Service
- 15.3. Market Value Forecast, by Technology, 2020-2034
- 15.3.1. Molecular Diagnostics
- 15.3.2. Hematology
- 15.3.3. Immunodiagnostics
- 15.3.4. Others
- 15.4. Market Value Forecast, by Derivative Type, 2020-2034
- 15.4.1. Immunoglobulin
- 15.4.2. Fibrinogen
- 15.4.3. Serum Albumin
- 15.4.4. Fetal Bovine Serum
- 15.4.5. Thrombin
- 15.4.6. Transferrin
- 15.4.7. Others
- 15.5. Market Value Forecast, by Source, 2020-2034
- 15.5.1. US Grade
- 15.5.2. Australia Grade
- 15.5.3. New Zealand Grade
- 15.5.4. Others
- 15.6. Market Value Forecast, by End-user, 2020-2034
- 15.6.1. Veterinary Industry
- 15.6.1.1. Veterinary Hospitals
- 15.6.1.2. Veterinary Reference Laboratories
- 15.6.1.3. POC/In House Testing
- 15.6.1.4. Veterinary Research laboratories
- 15.6.2. Food Industry
- 15.6.3. Academic and Research Institutes
- 15.6.4. Cell Culture/ Biotechnology
- 15.6.5. Cosmetic Industry
- 15.6.6. Pharmaceutical Industry
- 15.6.7. Diagnostics Industry
- 15.6.8. Others
- 15.7. Market Value Forecast, by Country/Sub-region, 2020-2034
- 15.7.1. Brazil
- 15.7.2. Mexico
- 15.7.3. Rest of Latin America
- 15.8. Market Attractiveness Analysis
- 15.8.1. By Product
- 15.8.2. By Technology
- 15.8.3. By Derivative Type
- 15.8.4. By Source
- 15.8.5. By End-user
- 15.8.6. By Country/Sub-region
16. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast
- 16.1. Introduction
- 16.2. Market Value Forecast, by Product, 2020-2034
- 16.2.1. Kits and Reagents
- 16.2.2. Instruments
- 16.2.3. Software and Service
- 16.3. Market Value Forecast, by Technology, 2020-2034
- 16.3.1. Molecular Diagnostics
- 16.3.2. Hematology
- 16.3.3. Immunodiagnostics
- 16.3.4. Others
- 16.4. Market Value Forecast, by Derivative Type, 2020-2034
- 16.4.1. Immunoglobulin
- 16.4.2. Fibrinogen
- 16.4.3. Serum Albumin
- 16.4.4. Fetal Bovine Serum
- 16.4.5. Thrombin
- 16.4.6. Transferrin
- 16.4.7. Others
- 16.5. Market Value Forecast, by Source, 2020-2034
- 16.5.1. US Grade
- 16.5.2. Australia Grade
- 16.5.3. New Zealand Grade
- 16.5.4. Others
- 16.6. Market Value Forecast, by End-user, 2020-2034
- 16.6.1. Veterinary Industry
- 16.6.1.1. Veterinary Hospitals
- 16.6.1.2. Veterinary Reference Laboratories
- 16.6.1.3. POC/In House Testing
- 16.6.1.4. Veterinary Research laboratories
- 16.6.2. Food Industry
- 16.6.3. Academic and Research Institutes
- 16.6.4. Cell Culture/ Biotechnology
- 16.6.5. Cosmetic Industry
- 16.6.6. Pharmaceutical Industry
- 16.6.7. Diagnostics Industry
- 16.6.8. Others
- 16.7. Market Value Forecast, by Country/Sub-region, 2020-2034
- 16.7.1. GCC Countries
- 16.7.2. South Africa
- 16.7.3. Rest of Middle East & Africa
- 16.8. Market Attractiveness Analysis
- 16.8.1. By Product
- 16.8.2. By Technology
- 16.8.3. By Derivative Type
- 16.8.4. By Source
- 16.8.5. By End-user
- 16.8.6. By Country/Sub-region
17. Competition Landscape
- 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 17.2. Market Share Analysis, by Company (2023)
- 17.3. Company Profiles
- 17.3.1. ANZCO Foods (Itoham Yonekyu Holdings)
- 17.3.1.1. Company Overview
- 17.3.1.2. Financial Overview
- 17.3.1.3. Product Portfolio
- 17.3.1.4. Business Strategies
- 17.3.1.5. Recent Developments
- 17.3.2. Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare)
- 17.3.2.1. Company Overview
- 17.3.2.2. Financial Overview
- 17.3.2.3. Product Portfolio
- 17.3.2.4. Business Strategies
- 17.3.2.5. Recent Developments
- 17.3.3. Moregate Biotech (ANZCO Foods)
- 17.3.3.1. Company Overview
- 17.3.3.2. Financial Overview
- 17.3.3.3. Product Portfolio
- 17.3.3.4. Business Strategies
- 17.3.3.5. Recent Developments
- 17.3.4. Proliant Health & Biologicals
- 17.3.4.1. Company Overview
- 17.3.4.2. Financial Overview
- 17.3.4.3. Product Portfolio
- 17.3.4.4. Business Strategies
- 17.3.4.5. Recent Developments
- 17.3.5. LAMPIRE Biological Laboratories, Inc.
- 17.3.5.1. Company Overview
- 17.3.5.2. Financial Overview
- 17.3.5.3. Product Portfolio
- 17.3.5.4. Business Strategies
- 17.3.5.5. Recent Developments
- 17.3.6. Rocky Mountain Biologicals, LLC
- 17.3.6.1. Company Overview
- 17.3.6.2. Financial Overview
- 17.3.6.3. Product Portfolio
- 17.3.6.4. Business Strategies
- 17.3.6.5. Recent Developments
- 17.3.7. Thermo Fisher Scientific Inc.
- 17.3.7.1. Company Overview
- 17.3.7.2. Financial Overview
- 17.3.7.3. Product Portfolio
- 17.3.7.4. Business Strategies
- 17.3.7.5. Recent Developments
- 17.3.8. Sigma-Aldrich (Merck KGaA)
- 17.3.8.1. Company Overview
- 17.3.8.2. Financial Overview
- 17.3.8.3. Product Portfolio
- 17.3.8.4. Business Strategies
- 17.3.8.5. Recent Developments
- 17.3.9. Kraeber & Co GmbH
- 17.3.9.1. Company Overview
- 17.3.9.2. Financial Overview
- 17.3.9.3. Product Portfolio
- 17.3.9.4. Business Strategies
- 17.3.9.5. Recent Developments
- 17.3.10. Auckland BioSciences
- 17.3.10.1. Company Overview
- 17.3.10.2. Financial Overview
- 17.3.10.3. Product Portfolio
- 17.3.10.4. Business Strategies
- 17.3.10.5. Recent Developments
- 17.3.11. Lake Immunogenics
- 17.3.11.1. Company Overview
- 17.3.11.2. Financial Overview
- 17.3.11.3. Product Portfolio
- 17.3.11.4. Business Strategies
- 17.3.11.5. Recent Developments
